Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD

We assessed the risk of chronic kidney disease (CKD) in chronic hepatitis C virus (HCV)‐infected patients and the incidence reduction of CKD after receipt of HCV treatment. We also evaluated the risk of membranoproliferative glomerulonephritis (MPGN) and cryoglobulinemia in chronic HCV patients. A r...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Haesuk, Chen, Chao, Wang, Wei, Henry, Linda, Cook, Robert L., Nelson, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814730/
https://www.ncbi.nlm.nih.gov/pubmed/28873225
http://dx.doi.org/10.1002/hep.29505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814730/
https://www.ncbi.nlm.nih.gov/pubmed/28873225
http://dx.doi.org/10.1002/hep.29505

Ejemplares similares